Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells

Triple-negative breast cancer (TNBC) has a poor prognosis as the therapy has several limitations, most importantly, treatment resistance. In this study we examined the different responses of triple-negative breast cancer line MDA-MB-231 and hormone receptor-positive breast cancer line MCF7 to a comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreidesz, Kitti, Koszegi, Balazs, Kovacs, Dominika, Bagone Vantus, Viola, Gallyas, Ferenc, Kovacs, Krisztina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921931/
https://www.ncbi.nlm.nih.gov/pubmed/33669671
http://dx.doi.org/10.3390/ijms22042056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921931/
https://www.ncbi.nlm.nih.gov/pubmed/33669671
http://dx.doi.org/10.3390/ijms22042056

Ejemplares similares